337 related articles for article (PubMed ID: 30350239)
1. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer-Cardiovascular Cohort.
Bao X; Borné Y; Muhammad IF; Nilsson J; Lind L; Melander O; Niu K; Orho-Melander M; Engström G
Diabetologia; 2019 Jan; 62(1):78-86. PubMed ID: 30350239
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.
Kempf T; Guba-Quint A; Torgerson J; Magnone MC; Haefliger C; Bobadilla M; Wollert KC
Eur J Endocrinol; 2012 Nov; 167(5):671-8. PubMed ID: 22918303
[TBL] [Abstract][Full Text] [Related]
3. Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality.
Bao X; Xu B; Muhammad IF; Nilsson PM; Nilsson J; Engström G
Diabetologia; 2022 Oct; 65(10):1642-1651. PubMed ID: 35922613
[TBL] [Abstract][Full Text] [Related]
4. GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes.
Pavo N; Wurm R; Neuhold S; Adlbrecht C; Vila G; Strunk G; Clodi M; Resl M; Brath H; Prager R; Luger A; Pacher R; Hülsmann M
Clin Chem; 2016 Dec; 62(12):1612-1620. PubMed ID: 27756762
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 and incident chronic kidney disease: a population-based cohort study.
Bao X; Xu B; Borné Y; Orho-Melander M; Melander O; Nilsson J; Christensson A; Engström G
BMC Nephrol; 2021 Oct; 22(1):351. PubMed ID: 34706669
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.
Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J
Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809
[No Abstract] [Full Text] [Related]
8. Acute-phase proteins and incidence of diabetes: a population-based cohort study.
Muhammad IF; Borné Y; Hedblad B; Nilsson PM; Persson M; Engström G
Acta Diabetol; 2016 Dec; 53(6):981-989. PubMed ID: 27581604
[TBL] [Abstract][Full Text] [Related]
9. [Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].
Yang XY; Zhang M; Luo XP; Wang JJ; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Zhang HY; Zhou JM; Han CY; Zhao Y; Feng TP; Hu DS; Zhao JZ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):328-33. PubMed ID: 27029364
[TBL] [Abstract][Full Text] [Related]
10. Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study.
Echouffo-Tcheugui JB; Daya N; Ndumele CE; Matsushita K; Hoogeveen RC; Ballantyne CM; Coresh J; Shah AM; Selvin E
Diabetologia; 2022 Jun; 65(6):955-963. PubMed ID: 35275240
[TBL] [Abstract][Full Text] [Related]
11. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
Au Yeung SL; Luo S; Schooling CM
Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
[TBL] [Abstract][Full Text] [Related]
12. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.
Vila G; Riedl M; Anderwald C; Resl M; Handisurya A; Clodi M; Prager G; Ludvik B; Krebs M; Luger A
Clin Chem; 2011 Feb; 57(2):309-16. PubMed ID: 21164037
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and Growth Differentiation Factor 15 in older adults.
Carballo-Casla A; García-Esquinas E; Buño-Soto A; Struijk EA; López-García E; Rodríguez-Artalejo F; Ortolá R
Geroscience; 2022 Apr; 44(2):867-880. PubMed ID: 33961185
[TBL] [Abstract][Full Text] [Related]
14. Circulating HER2/ErbB2 Levels Are Associated With Increased Incidence of Diabetes: A Population-Based Cohort Study.
Muhammad IF; Borné Y; Bao X; Melander O; Orho-Melander M; Nilsson PM; Nilsson J; Engström G
Diabetes Care; 2019 Aug; 42(8):1582-1588. PubMed ID: 31201260
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: Findings from Da Qing IGT and Diabetes Study.
Qian X; He S; Shen X; Shi N; Gong Q; An Y; Chen Y; Wang J; Li G
Diabetes Metab; 2022 Nov; 48(6):101380. PubMed ID: 35918035
[TBL] [Abstract][Full Text] [Related]
16. Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
Andersson C; Enserro D; Sullivan L; Wang TJ; Januzzi JL; Benjamin EJ; Vita JA; Hamburg NM; Larson MG; Mitchell GF; Vasan RS
Atherosclerosis; 2016 May; 248():245-51. PubMed ID: 26972631
[TBL] [Abstract][Full Text] [Related]
17. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
Melander O; Maisel AS; Almgren P; Manjer J; Belting M; Hedblad B; Engström G; Kilger U; Nilsson P; Bergmann A; Orho-Melander M
JAMA; 2012 Oct; 308(14):1469-75. PubMed ID: 23047361
[TBL] [Abstract][Full Text] [Related]
18. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus.
Engström G; Smith JG; Persson M; Nilsson PM; Melander O; Hedblad B
J Intern Med; 2014 Aug; 276(2):174-83. PubMed ID: 24471821
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Deichgræber P; Witte DR; Møller HJ; Skriver MV; Richelsen B; Jørgensen ME; Johansen NB; Sandbæk A
Diabetologia; 2016 Nov; 59(11):2467-2476. PubMed ID: 27541014
[TBL] [Abstract][Full Text] [Related]
20. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
